The countries in Asia have different languages, cultures and religion. Some of them are even a melting pot of people from different linguistic, cultural and historical backgrounds. This diversity often makes it difficult...
The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdependent biotechnology firms can exist and support each other directly and indirectly with or without the...
Government policies are among the major challenges before companies operating in the life sciences sector in the Asia Pacific region. For larger multinationals, policies favouring local companies prove to be hurdles. While...
Lack of appropriate funding for early- to mid-stage innovation companies, limited local capital, local grants for small biotechnology firms related to the percentage of GDP spent on research (unlike the support available...
The Asia Pacific healthcare market is estimated to capture 34.6 percent of the global healthcare market by 2015. Frost & Sullivan says that by 2020, healthcare expenditure in the APAC will increase 151 percent over 2010 figure,...
Survey Box
Recieve BioSpectrum Magazine to your door, from only $29 for 8 issues a year...
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
